SES Successfully Prices €650 million of SPACE Hybrid Securities
LUXEMBOURG–(BUSINESS WIRE)–NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN, OR AT ANY ADDRESS IN, THE... Read more.
INVESTOR ALERT: Securities Class Action Filed Against Grocery Outlet Holding Corp. – Investors Encouraged to Contact Kirby McInerney LLP
NEW YORK–(BUSINESS WIRE)–The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired... Read more.
Infinity Natural Resources Announces Pricing of Upsized Offering of $550 Million of 7.625% Senior Notes due 2031
MORGANTOWN, W. Va.–(BUSINESS WIRE)–Infinity Natural Resources, Inc. (“Infinity” or the “Company”) (NYSE: INR) today announced that its subsidiary,... Read more.
Rimini Street Announces Participation in the ROTH Capital Partners 38th Annual Investor Conference
LAS VEGAS–(BUSINESS WIRE)–Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, managed services and Agentic... Read more.
Research Quest Celebrates 10-Year Anniversary and 1 Million Learning Sessions
Museum-Built Resource Used by Teachers Worldwide SALT LAKE CITY–(BUSINESS WIRE)–The Natural History Museum of Utah’s (NHMU) free, award‑winning online... Read more.
Verastem Oncology Announces Abstracts Accepted for Presentation on AVMAPKI™ FAKZYNJA™ (avutometinib capsules; defactinib tablets) Combination Therapy at the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancers
Plenary oral presentation features long-term follow-up data from the Phase 2 RAMP 201 recurrent low-grade serous ovarian cancer clinical trial BOSTON–(BUSINESS... Read more.
JPMorganChase to Host First-Quarter 2026 Earnings Call
NEW YORK–(BUSINESS WIRE)–As previously announced, JPMorgan Chase & Co. (NYSE: JPM) (“JPMorganChase” or the “Firm”) will host a conference... Read more.
Fifth Third Bancorp Announces Cash Dividends
CINCINNATI–(BUSINESS WIRE)–Today, Fifth Third Bancorp announced the declaration of cash dividends on its common shares, Series H preferred shares, Series... Read more.
Agenus Announces Upcoming AACR 2026 Presentation Evaluating Botensilimab Plus Balstilimab in First-Line MSS Metastatic Colorectal Cancer
A novel, chemo-sparing strategy (BBoPCO): introducing BOT+BAL in 1L MSS mCRC to extend survival and reduce use of cytotoxic chemotherapy LEXINGTON, Mass.–(BUSINESS... Read more.
Zai Lab to Present New Data on Three Internally Developed Oncology Candidates at AACR 2026, Including Zocilurtatug Pelitecan, a DLL3-Targeting Antibody-Drug Conjugate (ADC)
– Zoci data show intracranial response in small-cell lung cancer (SCLC) with brain metastases, as well as activity in other neuroendocrine carcinomas –... Read more.